ABSTRACT
The basic structure of the nervous system is neurons and the connections formed by nerve fibers. Identifying different types of neurons in different parts of the nervous system, revealing the efferent and afferent nerve fibers they constitute, and elucidating the neuroactive substances and receptors involved, provide the basis for the regulation of neuronal activity and the uncovering of how the nervous system works. It is also the goal of neuroanatomy research. The rapid development of modern science and technology and interdisciplinary penetration require us to conduct in-depth neuroanatomy studies on specific neural pathways composed of specific types of neurons using specific neuroactive substances for specific neural functions. This also provides a good opportunity for us to clarify the structure of nervous system and analyze its working principle from macroscopic, mesoscopic and microscopic levels.
ABSTRACT
The use of pharmacological agents is often the preferred approach to the management of vestibular dysfunction. In the vestibular sensory pathways, the sensory neuroepithelia are thought to be influenced by a diverse number of neuroactive substances that may act to enhance or inhibit the effect of the primary neurotransmitters [i.e., glutamate (Glu) and acetylcholine (ACh)] or alter their patterns of release. This review summarizes various efforts to identify drug targets including neurotransmitter and neuromodulator receptors in the vestibular sensory pathways. Identifying these receptor targets provides a strategic basis to use specific pharmacological tools to modify receptor function in the treatment and management of debilitating balance disorders. A review of the literature reveals that most investigations of the neuropharmacology of peripheral vestibular function have been performed using in vitro or ex vivo animal preparations rather than studying drug action on the normal intact vestibular system in situ. Such noninvasive approaches could aid the development of more accurate and effective intervention strategies for the treatment of dizziness and vertigo. The current review explores the major neuropharmacological targets for drug action in the vestibular system.
Subject(s)
Animals , Acetylcholine , Dizziness , Glutamic Acid , In Vitro Techniques , Neuropharmacology , Neurotransmitter Agents , Receptors, Neurotransmitter , VertigoABSTRACT
The use of pharmacological agents is often the preferred approach to the management of vestibular dysfunction. In the vestibular sensory pathways, the sensory neuroepithelia are thought to be influenced by a diverse number of neuroactive substances that may act to enhance or inhibit the effect of the primary neurotransmitters [i.e., glutamate (Glu) and acetylcholine (ACh)] or alter their patterns of release. This review summarizes various efforts to identify drug targets including neurotransmitter and neuromodulator receptors in the vestibular sensory pathways. Identifying these receptor targets provides a strategic basis to use specific pharmacological tools to modify receptor function in the treatment and management of debilitating balance disorders. A review of the literature reveals that most investigations of the neuropharmacology of peripheral vestibular function have been performed using in vitro or ex vivo animal preparations rather than studying drug action on the normal intact vestibular system in situ. Such noninvasive approaches could aid the development of more accurate and effective intervention strategies for the treatment of dizziness and vertigo. The current review explores the major neuropharmacological targets for drug action in the vestibular system.